HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
26:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
scribed in  combination  with  other  heart-failure  thera-:@0.076190:0.084931:0.480957:0.084931:0.480957:0.069149:0.076190:0.069149:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.007242:0.003024:0.009223:0.004188:0.003039:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003039:0.012564:0.003024:0.005125:0.009223:0.004188:0.003039:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.003024:0.009223:0.009827:0.010326:0.004551:0.005125:0.005020:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.003039:0.005125:0.009223:0.009827:0.004551:0.010341:0.005020
pies, excluding ACE inhibitors and ARBs. In the  south :@0.076190:0.099190:0.485160:0.099190:0.485160:0.083407:0.076190:0.083407:0.010311:0.003024:0.009827:0.005866:0.004188:0.007257:0.009827:0.007257:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.007257:0.011188:0.012292:0.008104:0.007257:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.007257:0.010326:0.009223:0.010357:0.007257:0.011188:0.009177:0.008678:0.005866:0.004188:0.007257:0.003417:0.009223:0.007257:0.005125:0.009223:0.009827:0.004188:0.003069:0.007529:0.009903:0.009192:0.005125:0.009223:0.004188
African setting, Entresto  is  indicated as second-line :@0.076190:0.113449:0.485133:0.113446:0.485133:0.097664:0.076190:0.097666:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.009223:0.008981:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.004188:0.008981:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903:0.006534:0.008981:0.003024:0.005866:0.004188:0.004808:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.008981:0.010326:0.005866:0.008981:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.005020:0.003024:0.003024:0.009223:0.009827:0.700686
®:@0.257254:0.108147:0.263805:0.108147:0.263805:0.098994:0.257254:0.098994:0.006550
therapy, replacing ACE inhibitors or ARBs in the treat-:@0.076193:0.127705:0.480960:0.127705:0.480960:0.111922:0.076193:0.111922:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.006531:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.003024:0.009223:0.010175:0.006531:0.011188:0.012292:0.008104:0.006531:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.006531:0.009903:0.004551:0.006531:0.011188:0.009177:0.008678:0.005866:0.006531:0.003024:0.009223:0.006531:0.005125:0.009223:0.009827:0.006531:0.005125:0.004551:0.009827:0.010326:0.005125:0.005020
ment of symptomatic heart failure Class II to Class IV for :@0.076193:0.141963:0.485133:0.141963:0.485133:0.126181:0.076193:0.126181:0.014182:0.009827:0.009223:0.005125:0.004218:0.009903:0.004747:0.004218:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.004218:0.009223:0.009827:0.010326:0.004551:0.005125:0.004218:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004218:0.012292:0.003024:0.010326:0.005866:0.005866:0.004233:0.003417:0.003417:0.004218:0.005125:0.009903:0.004218:0.012292:0.003024:0.010326:0.005866:0.005866:0.004233:0.003417:0.010614:0.004233:0.004747:0.009903:0.004551:0.004188
patients with HF EF.  :@0.076193:0.156222:0.224203:0.156219:0.224203:0.140436:0.076193:0.140439:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.010326:0.007333:0.004551:0.008104:0.007333:0.004188:0.004848:0.905604
r:@0.190992:0.156222:0.195543:0.156222:0.195543:0.140439:0.190992:0.140439:0.004551
3:@0.215156:0.150920:0.220014:0.150920:0.220014:0.141766:0.215156:0.141766:0.004858
Entresto   resulted  in a 20% reduction  in  death  from :@0.090476:0.170477:0.485139:0.170476:0.485139:0.154693:0.090476:0.154695:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903:0.006542:0.004188:0.002797:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.009827:0.010357:0.004188:0.002797:0.003024:0.009223:0.007000:0.010326:0.007000:0.008376:0.008376:0.011717:0.007000:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002797:0.003024:0.009223:0.004188:0.002797:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188:0.002797:0.004747:0.004551:0.009903:0.014182:0.625998
®:@0.148191:0.165177:0.154742:0.165177:0.154742:0.156023:0.148191:0.156023:0.006550
cardiovascular causes and a 21% reduction in hospitali-:@0.076184:0.184735:0.480920:0.184735:0.480920:0.168952:0.076184:0.168952:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.003961:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.003961:0.010326:0.009223:0.010357:0.003961:0.010326:0.003961:0.008376:0.008376:0.011717:0.003961:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.003946:0.003024:0.009223:0.003961:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005020
sation for heart failure. There was also a 16% relative risk :@0.076184:0.198993:0.485093:0.198993:0.485093:0.183211:0.076184:0.183211:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004248:0.004747:0.009903:0.004551:0.004248:0.009223:0.009827:0.010326:0.004551:0.005110:0.004248:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.004248:0.006441:0.009223:0.009827:0.004551:0.009827:0.004233:0.012564:0.010326:0.005866:0.004264:0.010326:0.003024:0.005866:0.009903:0.004248:0.010326:0.004248:0.008376:0.008376:0.011717:0.004248:0.004551:0.009827:0.003024:0.010326:0.005125:0.003024:0.008376:0.009827:0.004248:0.004551:0.003024:0.005866:0.007590:0.004188
reduction in all-cause mortality. The risk of sudden death :@0.076184:0.213252:0.485124:0.213252:0.485124:0.197469:0.076184:0.197469:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.003326:0.003024:0.009223:0.003341:0.010326:0.003024:0.003024:0.005020:0.009782:0.010326:0.009192:0.005866:0.009827:0.003356:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.003341:0.006441:0.009223:0.009827:0.003341:0.004551:0.003024:0.005866:0.007590:0.003341:0.009903:0.004747:0.003341:0.005866:0.009192:0.010357:0.010357:0.009827:0.009223:0.003341:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188
was also reduced by 20%. There were 30% fewer pres-:@0.076184:0.227510:0.480951:0.227510:0.480951:0.211728:0.076184:0.211728:0.012564:0.010326:0.005866:0.005534:0.010326:0.003024:0.005866:0.009903:0.005518:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.005518:0.010311:0.008104:0.005534:0.008376:0.008376:0.011717:0.004188:0.005534:0.006441:0.009223:0.009827:0.004551:0.009827:0.005518:0.012564:0.009827:0.004551:0.009827:0.005518:0.008376:0.008376:0.011717:0.005534:0.004747:0.009827:0.012564:0.009827:0.004551:0.005518:0.010311:0.004551:0.009827:0.005866:0.005020
entations to the emergency unit, 18% fewer admissions :@0.076184:0.241769:0.485108:0.241769:0.485108:0.225986:0.076184:0.225986:0.009827:0.009223:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004853:0.005125:0.009903:0.004853:0.005125:0.009223:0.009827:0.004868:0.009827:0.014182:0.009827:0.004551:0.010175:0.009827:0.009223:0.009782:0.008104:0.004853:0.009192:0.009223:0.003024:0.005125:0.004188:0.004868:0.008376:0.008376:0.011717:0.004868:0.004747:0.009827:0.012564:0.009827:0.004551:0.004853:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005866:0.004188
to ICU and 12% lower risk of all-cause hospitalisation in :@0.076184:0.256028:0.485108:0.256028:0.485108:0.240245:0.076184:0.240245:0.005125:0.009903:0.005352:0.003417:0.012292:0.009903:0.005352:0.010326:0.009223:0.010357:0.005367:0.008376:0.008376:0.011717:0.005367:0.003024:0.009903:0.012564:0.009827:0.004551:0.005352:0.004551:0.003024:0.005866:0.007590:0.005367:0.009903:0.004747:0.005352:0.010326:0.003024:0.003024:0.005020:0.009782:0.010326:0.009192:0.005866:0.009827:0.005367:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.005367:0.003024:0.009223:0.004188
patients treated. The use of Entresto:@0.076184:0.270286:0.348447:0.270286:0.348447:0.254504:0.076184:0.254504:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006274:0.005125:0.004551:0.009827:0.010326:0.005125:0.009812:0.010357:0.004188:0.006274:0.006441:0.009223:0.009827:0.006274:0.009192:0.005866:0.009827:0.006274:0.009903:0.004747:0.006274:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903
®:@0.348459:0.264979:0.355010:0.264979:0.355010:0.255825:0.348459:0.255825:0.006550
 also significantly :@0.355010:0.270278:0.485140:0.270278:0.485140:0.254495:0.355010:0.254495:0.006274:0.010326:0.003024:0.005866:0.009903:0.006290:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003024:0.008104:0.004188
improved quality of life.:@0.076185:0.284537:0.247847:0.284537:0.247847:0.268754:0.076185:0.268754:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.010357:0.004188:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.009903:0.004747:0.004188:0.003024:0.003024:0.004747:0.009827:0.004188
1:@0.247852:0.279237:0.252710:0.279237:0.252710:0.270083:0.247852:0.270083:0.004858
The pARADIGM-HF trial,:@0.090476:0.298793:0.259189:0.298793:0.259189:0.283010:0.090476:0.283010:0.006441:0.009223:0.009827:0.004037:0.008950:0.011188:0.009162:0.011188:0.011249:0.003417:0.013184:0.013894:0.005020:0.010326:0.007333:0.004037:0.005125:0.004551:0.003024:0.010326:0.003024:0.004188
1:@0.259194:0.293494:0.264052:0.293494:0.264052:0.284340:0.259194:0.284340:0.004858
 therefore, represents a signifi:@0.264054:0.298793:0.475933:0.298793:0.475933:0.283010:0.264054:0.283010:0.004037:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004188:0.004022:0.004551:0.009827:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.005866:0.004037:0.010326:0.004037:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681
-:@0.475933:0.298793:0.480952:0.298793:0.480952:0.283010:0.475933:0.283010:0.005020
cant landmark in the study of heart-failure therapy. :@0.076185:0.313052:0.453859:0.313052:0.453859:0.297269:0.076185:0.297269:0.009782:0.010326:0.009223:0.005125:0.004188:0.003024:0.010326:0.009223:0.010357:0.014182:0.010326:0.004551:0.007590:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.005866:0.005125:0.009192:0.010357:0.008104:0.004188:0.009903:0.004747:0.004188:0.009223:0.009827:0.010326:0.004551:0.005125:0.005020:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004188
When initiating Entresto , it is essential to stop the ACE :@0.090473:0.327310:0.485135:0.327308:0.485135:0.311525:0.090473:0.311528:0.014514:0.009223:0.009827:0.009223:0.004082:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.004097:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903:0.006542:0.004188:0.004082:0.003024:0.005125:0.004097:0.003024:0.005866:0.004097:0.009827:0.005866:0.005866:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.004097:0.005125:0.009903:0.004082:0.005866:0.005125:0.009903:0.010311:0.004082:0.005125:0.009223:0.009827:0.004082:0.011188:0.012292:0.008104:0.420627
®:@0.260447:0.322009:0.266997:0.322009:0.266997:0.312855:0.260447:0.312855:0.006550
inhibitor  and ARB  for  36 hours  before  administration. :@0.076196:0.341566:0.485135:0.341566:0.485135:0.325784:0.076196:0.325784:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.003961:0.010326:0.009223:0.010357:0.008164:0.011188:0.009177:0.008678:0.004188:0.003961:0.004747:0.009903:0.004551:0.004188:0.003961:0.008376:0.008376:0.008164:0.009223:0.009903:0.009192:0.004551:0.005866:0.004188:0.003961:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.004188:0.003961:0.010326:0.010357:0.014182:0.003024:0.009223:0.003024:0.005866:0.005125:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
The initial dose in most patients will  be 100  mg twice :@0.076196:0.355825:0.485151:0.355825:0.485151:0.340042:0.076196:0.340042:0.006441:0.009223:0.009827:0.006879:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.006879:0.010357:0.009903:0.005866:0.009827:0.006879:0.003024:0.009223:0.006879:0.014182:0.009903:0.005866:0.005125:0.006879:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006879:0.012564:0.003024:0.003024:0.003024:0.004188:0.002706:0.010311:0.009827:0.006879:0.008376:0.008376:0.008376:0.004188:0.002706:0.014182:0.010175:0.006879:0.005125:0.012564:0.003024:0.009782:0.009827:0.004188
a day. After three to four weeks, therapeutic doses of :@0.076196:0.370084:0.485135:0.370084:0.485135:0.354301:0.076196:0.354301:0.010326:0.005715:0.010357:0.010326:0.008104:0.004188:0.005715:0.011188:0.004747:0.005125:0.009827:0.004551:0.005700:0.005125:0.009223:0.004551:0.009827:0.009827:0.005715:0.005125:0.009903:0.005715:0.004747:0.009903:0.009192:0.004551:0.005700:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.005715:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.009827:0.009192:0.005125:0.003024:0.009782:0.005700:0.010357:0.009903:0.005866:0.009827:0.005866:0.005715:0.009903:0.004747:0.004188
200  mg twice daily  may be used, if tolerated.  should :@0.076196:0.384342:0.485151:0.384342:0.485151:0.368560:0.076196:0.368560:0.008376:0.008376:0.008376:0.004188:0.002343:0.014182:0.010175:0.006516:0.005125:0.012564:0.003024:0.009782:0.009827:0.006516:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.002343:0.014182:0.010326:0.008104:0.006516:0.010311:0.009827:0.006516:0.009192:0.005866:0.009827:0.010357:0.004188:0.006516:0.003024:0.004747:0.006516:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.004188:0.002343:0.007529:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188
the patients be on low doses of an ARB or ACE inhibi-:@0.076196:0.398601:0.480932:0.398601:0.480932:0.382818:0.076196:0.382818:0.005125:0.009223:0.009827:0.005730:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005730:0.010311:0.009827:0.005730:0.009903:0.009223:0.005730:0.003024:0.009903:0.012564:0.005730:0.010357:0.009903:0.005866:0.009827:0.005866:0.005730:0.009903:0.004747:0.005730:0.010326:0.009223:0.005730:0.011188:0.009177:0.008678:0.005730:0.009903:0.004551:0.005730:0.011188:0.012292:0.008104:0.005730:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005020
tor, the same process of stopping these agents within :@0.076196:0.412860:0.485151:0.412860:0.485151:0.397077:0.076196:0.397077:0.005125:0.009903:0.004551:0.004188:0.006153:0.005125:0.009223:0.009827:0.006169:0.005866:0.010326:0.014182:0.009827:0.006169:0.010311:0.004551:0.009903:0.009782:0.009827:0.005866:0.005866:0.006169:0.009903:0.004747:0.006169:0.005866:0.005125:0.009903:0.010311:0.010311:0.003024:0.009223:0.010175:0.006169:0.005125:0.009223:0.009827:0.005866:0.009827:0.006169:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.006169:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188
36 hours applies. Then start with a slightly lower dose of :@0.076196:0.427118:0.485151:0.427118:0.485151:0.411336:0.076196:0.411336:0.008376:0.008376:0.004838:0.009223:0.009903:0.009192:0.004551:0.005866:0.004838:0.010326:0.010311:0.010311:0.003024:0.003024:0.009827:0.005866:0.004188:0.004853:0.006441:0.009223:0.009827:0.009223:0.004823:0.005866:0.005125:0.010326:0.004551:0.005125:0.004838:0.012564:0.003024:0.005125:0.009223:0.004838:0.010326:0.004838:0.005866:0.003024:0.003024:0.010175:0.009223:0.005125:0.003024:0.008104:0.004853:0.003024:0.009903:0.012564:0.009827:0.004551:0.004838:0.010357:0.009903:0.005866:0.009827:0.004838:0.009903:0.004747:0.004188
Entresto , 50 mg twice a day, gradually uptitrating to a :@0.076196:0.441377:0.485141:0.441367:0.485141:0.425585:0.076196:0.425594:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903:0.006536:0.004188:0.004657:0.008376:0.008376:0.004672:0.014182:0.010175:0.004657:0.005125:0.012564:0.003024:0.009782:0.009827:0.004657:0.010326:0.004657:0.010357:0.010326:0.008104:0.004188:0.004657:0.010175:0.004551:0.010326:0.010357:0.009192:0.010326:0.003024:0.003024:0.008104:0.004672:0.009192:0.010311:0.005125:0.003024:0.005125:0.004551:0.010326:0.005125:0.003024:0.009223:0.010175:0.004657:0.005125:0.009903:0.004657:0.010326:0.271258
®:@0.133906:0.436069:0.140456:0.436069:0.140456:0.426915:0.133906:0.426915:0.006550
maximum of 200 mg twice a day over four to six weeks, :@0.076201:0.455626:0.485156:0.455626:0.485156:0.439843:0.076201:0.439843:0.014182:0.010326:0.007257:0.003024:0.014182:0.009192:0.014182:0.004248:0.009903:0.004747:0.004248:0.008376:0.008376:0.008376:0.004264:0.014182:0.010175:0.004248:0.005125:0.012564:0.003024:0.009782:0.009827:0.004248:0.010326:0.004248:0.010357:0.010326:0.008104:0.004248:0.009903:0.008376:0.009827:0.004551:0.004248:0.004747:0.009903:0.009192:0.004551:0.004248:0.005125:0.009903:0.004248:0.005866:0.003024:0.007257:0.004264:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.004188
if tolerated. Hypotension and renal dysfunction may oc-:@0.076201:0.469885:0.480968:0.469885:0.480968:0.454102:0.076201:0.454102:0.003024:0.004747:0.003598:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.003598:0.010326:0.008104:0.010311:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.003598:0.010326:0.009223:0.010357:0.003598:0.004551:0.009827:0.009223:0.010326:0.003024:0.003598:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.003598:0.014182:0.010326:0.008104:0.003598:0.009903:0.009782:0.005020
cur in the initial stages of treatment; however, with the :@0.076201:0.484143:0.485141:0.484143:0.485141:0.468361:0.076201:0.468361:0.009782:0.009192:0.004551:0.005125:0.003024:0.009223:0.005125:0.005125:0.009223:0.009827:0.005125:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.005125:0.005866:0.005125:0.010326:0.010175:0.009827:0.005866:0.005125:0.009903:0.004747:0.005125:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.005125:0.009223:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.005125:0.012564:0.003024:0.005125:0.009223:0.005125:0.005125:0.009223:0.009827:0.004188
continuation of treatment, these effects are expected :@0.076201:0.498402:0.485141:0.498402:0.485141:0.482619:0.076201:0.482619:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.010326:0.005125:0.003024:0.009903:0.009223:0.005443:0.009903:0.004747:0.005458:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.005443:0.005125:0.009223:0.009827:0.005866:0.009827:0.005458:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.005458:0.010326:0.004551:0.009827:0.005458:0.009827:0.007257:0.010311:0.009827:0.009782:0.005125:0.009827:0.010357:0.004188
gradually to decrease in frequency. The initial 36-hour :@0.076201:0.512660:0.485156:0.512660:0.485156:0.496878:0.076201:0.496878:0.010175:0.004551:0.010326:0.010357:0.009192:0.010326:0.003024:0.003024:0.008104:0.005912:0.005125:0.009903:0.005912:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005912:0.003024:0.009223:0.005912:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.009782:0.008104:0.004188:0.005912:0.006441:0.009223:0.009827:0.005912:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.005927:0.008376:0.008376:0.005020:0.009223:0.009903:0.009192:0.004551:0.004188
wait before administration is owing to the potential risk :@0.076201:0.526919:0.485141:0.526919:0.485141:0.511136:0.076201:0.511136:0.012564:0.010326:0.003024:0.005125:0.005171:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.005171:0.010326:0.010357:0.014182:0.003024:0.009223:0.003024:0.005866:0.005125:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.005171:0.003024:0.005866:0.005171:0.009903:0.012564:0.003024:0.009223:0.010175:0.005171:0.005125:0.009903:0.005171:0.005125:0.009223:0.009827:0.005171:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.005171:0.004551:0.003024:0.005866:0.007590:0.004188
of angio-oedema and hypotension with dual blockade :@0.076201:0.541178:0.485141:0.541178:0.485141:0.525395:0.076201:0.525395:0.009903:0.004747:0.004067:0.010326:0.009223:0.010175:0.003024:0.009903:0.005020:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.004067:0.010326:0.009223:0.010357:0.004067:0.009223:0.008104:0.010311:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004067:0.012564:0.003024:0.005125:0.009223:0.004067:0.010357:0.009192:0.010326:0.003024:0.004082:0.010311:0.003024:0.009903:0.009782:0.007590:0.010326:0.010357:0.009827:0.004188
of the RAAs. :@0.076201:0.555436:0.170861:0.555436:0.170861:0.539654:0.076201:0.539654:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.004188:0.009177:0.011188:0.011188:0.007529:0.004188:0.004188
Close attention  to  liver function,  potassium levels, :@0.090488:0.569695:0.485125:0.569695:0.485125:0.553912:0.090488:0.553912:0.012292:0.003024:0.009903:0.005866:0.009827:0.009419:0.010326:0.005125:0.005125:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004188:0.005216:0.005125:0.009903:0.004188:0.005216:0.003024:0.003024:0.008376:0.009827:0.004551:0.009419:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.005216:0.010311:0.009903:0.005125:0.010326:0.005866:0.005866:0.003024:0.009192:0.014182:0.009419:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188:0.004188
symptomatic hypotension, renal dysfunction and angio-:@0.076201:0.583954:0.480968:0.583954:0.480968:0.568171:0.076201:0.568171:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.003175:0.009223:0.008104:0.010311:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.003160:0.004551:0.009827:0.009223:0.010326:0.003024:0.003175:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.003160:0.010326:0.009223:0.010357:0.003175:0.010326:0.009223:0.010175:0.003024:0.009903:0.005020
oedema are important considerations when initiating :@0.076201:0.598212:0.485171:0.598212:0.485171:0.582430:0.076201:0.582430:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.007151:0.010326:0.004551:0.009827:0.007151:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.007151:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.007151:0.012564:0.009223:0.009827:0.009223:0.007151:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.004188
Entresto , preferably under specialist supervision. Dose :@0.076201:0.612471:0.485141:0.612457:0.485141:0.596674:0.076201:0.596688:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903:0.006531:0.004188:0.006244:0.010311:0.004551:0.009827:0.004747:0.009827:0.004551:0.010326:0.010311:0.003024:0.008104:0.006244:0.009192:0.009223:0.010357:0.009827:0.004551:0.006229:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.006244:0.005866:0.009192:0.010311:0.009827:0.004551:0.008376:0.003024:0.005866:0.003024:0.009903:0.009223:0.004188:0.006244:0.011249:0.009903:0.005866:0.009827:0.047212
®:@0.133906:0.607158:0.140456:0.607158:0.140456:0.598004:0.133906:0.598004:0.006550
adjustment  may be required,  depending  on  adverse :@0.076186:0.626715:0.485125:0.626715:0.485125:0.610933:0.076186:0.610933:0.010326:0.010357:0.003069:0.009192:0.005866:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003024:0.014182:0.010326:0.008104:0.007227:0.010311:0.009827:0.007227:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.004188:0.004188:0.003024:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.003024:0.009223:0.010175:0.004188:0.003024:0.009903:0.009223:0.004188:0.003024:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.004188
events. There is no robust evidence linking Entresto  to :@0.076186:0.640974:0.485152:0.640972:0.485152:0.625189:0.076186:0.625191:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188:0.005579:0.006441:0.009223:0.009827:0.004551:0.009827:0.005579:0.003024:0.005866:0.005594:0.009223:0.009903:0.005579:0.004551:0.009903:0.010311:0.009192:0.005866:0.005125:0.005579:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.005579:0.003024:0.003024:0.009223:0.007590:0.003024:0.009223:0.010175:0.005594:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005125:0.009903:0.006558:0.005594:0.005125:0.009903:0.009860
®:@0.453791:0.635673:0.460341:0.635673:0.460341:0.626519:0.453791:0.626519:0.006550
an increased incidence of dementia. Currently, Entres-:@0.076197:0.655230:0.480949:0.655230:0.480949:0.639448:0.076197:0.639448:0.010326:0.009223:0.004974:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004974:0.003024:0.009223:0.009782:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004974:0.009903:0.004747:0.004974:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.004188:0.004974:0.012292:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.004959:0.008104:0.009223:0.005125:0.004551:0.009827:0.005866:0.005020
to  is indicated as second-line therapy after failure of :@0.076197:0.669489:0.485129:0.669486:0.485129:0.653704:0.076197:0.653706:0.005125:0.009903:0.006539:0.006320:0.003024:0.005866:0.006335:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.006320:0.010326:0.005866:0.006335:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.005020:0.003024:0.003024:0.009223:0.009827:0.006320:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.006320:0.010326:0.004747:0.005125:0.009827:0.004551:0.006320:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.006320:0.009903:0.004747:-0.027458
®:@0.091213:0.664188:0.097764:0.664188:0.097764:0.655034:0.091213:0.655034:0.006550
ARBs and ACE inhibitor therapy for patients with HF EF. :@0.076190:0.683745:0.474924:0.683745:0.474924:0.667962:0.076190:0.667962:0.011188:0.009177:0.008678:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.011188:0.012292:0.008104:0.004188:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004747:0.009903:0.004551:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.010326:0.007333:0.004521:0.008104:0.007333:0.004188:0.004188
r:@0.446561:0.683745:0.451112:0.683745:0.451112:0.667962:0.446561:0.667962:0.004551
Diuretics :@0.076190:0.715072:0.150106:0.715072:0.150106:0.696740:0.076190:0.696740:0.011759:0.004032:0.010079:0.005376:0.010751:0.005040:0.004032:0.010751:0.007392:0.004704
Diuretics reduce  symptoms related  to  cardiac con-:@0.076190:0.731501:0.480972:0.731501:0.480972:0.715718:0.076190:0.715718:0.011249:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.009328:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.004188:0.005125:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.009328:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188:0.005125:0.005125:0.009903:0.004188:0.005125:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.009328:0.009782:0.009903:0.009223:0.005020
gestion. How they affect mortality has not been com-:@0.076190:0.745760:0.480942:0.745760:0.480942:0.729977:0.076190:0.729977:0.010175:0.009827:0.005866:0.005125:0.003024:0.009903:0.009223:0.004188:0.005836:0.010326:0.009903:0.012564:0.005836:0.005125:0.009223:0.009827:0.008104:0.005836:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.005836:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.005836:0.009223:0.010326:0.005866:0.005836:0.009223:0.009903:0.005125:0.005836:0.010311:0.009827:0.009827:0.009223:0.005836:0.009782:0.009903:0.014182:0.005020
prehensively studied  in  randomised  control  trials.  A :@0.076190:0.760018:0.485130:0.760018:0.485130:0.744236:0.076190:0.744236:0.010311:0.004551:0.009827:0.009223:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.003024:0.008104:0.010205:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.010357:0.004188:0.006002:0.003024:0.009223:0.004188:0.006002:0.004551:0.010326:0.009223:0.010357:0.009903:0.014182:0.003024:0.005866:0.009827:0.010357:0.004188:0.006002:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004188:0.006002:0.005125:0.004551:0.003024:0.010326:0.003024:0.005866:0.004188:0.004188:0.006002:0.011188:0.004188
Cochrane meta-analysis has shown that patients with :@0.076190:0.774277:0.485145:0.774277:0.485145:0.758494:0.076190:0.758494:0.012292:0.009903:0.009782:0.009223:0.004551:0.010326:0.009223:0.009827:0.006426:0.014182:0.009827:0.005125:0.010326:0.005020:0.010326:0.009223:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.006456:0.009223:0.010326:0.005866:0.006441:0.005866:0.009223:0.009903:0.012564:0.009223:0.006441:0.005125:0.009223:0.010326:0.005125:0.006441:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006441:0.012564:0.003024:0.005125:0.009223:0.004188
chronic  heart  failure treated  with diuretics had a de-:@0.076190:0.788536:0.480942:0.788536:0.480942:0.772753:0.076190:0.772753:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004188:0.002585:0.009223:0.009827:0.010326:0.004551:0.005125:0.004188:0.002585:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.006788:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.004188:0.002585:0.012564:0.003024:0.005125:0.009223:0.006788:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.006788:0.009223:0.010326:0.010357:0.006788:0.010326:0.006788:0.010357:0.009827:0.005020
creased risk of worsening heart failure and death when :@0.076190:0.802794:0.485130:0.802794:0.485130:0.787012:0.076190:0.787012:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004354:0.004551:0.003024:0.005866:0.007590:0.004354:0.009903:0.004747:0.004354:0.012564:0.009903:0.004551:0.005866:0.009827:0.009223:0.003024:0.009223:0.010175:0.004354:0.009223:0.009827:0.010326:0.004551:0.005125:0.004354:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004354:0.010326:0.009223:0.010357:0.004354:0.010357:0.009827:0.010326:0.005125:0.009223:0.004354:0.012564:0.009223:0.009827:0.009223:0.004188
compared to controls. Optimal diuretic therapy also im-:@0.076190:0.817053:0.480927:0.817053:0.480927:0.801270:0.076190:0.801270:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.009827:0.010357:0.003719:0.005125:0.009903:0.003719:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.005866:0.004188:0.003719:0.013138:0.010311:0.005125:0.003024:0.014182:0.010326:0.003024:0.003734:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.003734:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.003719:0.010326:0.003024:0.005866:0.009903:0.003734:0.003024:0.014182:0.005020
proves exercise capacity.:@0.076190:0.831312:0.264332:0.831312:0.264332:0.815529:0.076190:0.815529:0.010311:0.004551:0.009903:0.008376:0.009827:0.005866:0.004188:0.009827:0.007257:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827:0.004188:0.009782:0.010326:0.010311:0.010326:0.009782:0.003024:0.005125:0.008104:0.004188
A combination of loop and thiazide/thiazide-like :@0.090478:0.845570:0.485160:0.845570:0.485160:0.829788:0.090478:0.829788:0.011188:0.011566:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.011566:0.009903:0.004747:0.011566:0.003024:0.009903:0.009903:0.010311:0.011566:0.010326:0.009223:0.010357:0.011566:0.005125:0.009223:0.003024:0.010326:0.006426:0.003024:0.010357:0.009827:0.006607:0.005125:0.009223:0.003024:0.010326:0.006426:0.003024:0.010357:0.009827:0.005020:0.003024:0.003024:0.007590:0.009827:0.004188
diuretics is used to treat challenging patients. Howev-:@0.076190:0.859829:0.480942:0.859829:0.480942:0.844046:0.076190:0.844046:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.006259:0.003024:0.005866:0.006274:0.009192:0.005866:0.009827:0.010357:0.006259:0.005125:0.009903:0.006259:0.005125:0.004551:0.009827:0.010326:0.005125:0.006259:0.009782:0.009223:0.010326:0.003024:0.003024:0.009827:0.009223:0.010175:0.003024:0.009223:0.010175:0.006259:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.006259:0.010326:0.009903:0.012564:0.009827:0.008376:0.005020
er, the risk of electrolyte disturbance, renal failure and :@0.076190:0.874087:0.485130:0.874087:0.485130:0.858305:0.076190:0.858305:0.009827:0.004551:0.004188:0.005609:0.005125:0.009223:0.009827:0.005609:0.004551:0.003024:0.005866:0.007590:0.005624:0.009903:0.004747:0.005609:0.009827:0.003024:0.009827:0.009782:0.005125:0.004551:0.009903:0.003024:0.008104:0.005125:0.009827:0.005609:0.010357:0.003024:0.005866:0.005125:0.009192:0.004551:0.010311:0.010326:0.009223:0.009782:0.009827:0.004188:0.005609:0.004551:0.009827:0.009223:0.010326:0.003024:0.005609:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005609:0.010326:0.009223:0.010357:0.004188
hypotension should always be kept in mind, and be pre-:@0.076190:0.888346:0.480957:0.888346:0.480957:0.872563:0.076190:0.872563:0.009223:0.008104:0.010311:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.003462:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003477:0.010326:0.003024:0.012564:0.010326:0.008104:0.005866:0.003492:0.010311:0.009827:0.003477:0.007590:0.009827:0.010311:0.005125:0.003477:0.003024:0.009223:0.003477:0.014182:0.003024:0.009223:0.010357:0.004188:0.003477:0.010326:0.009223:0.010357:0.003477:0.010311:0.009827:0.003477:0.010311:0.004551:0.009827:0.005020
vented.:@0.076190:0.902605:0.133114:0.902605:0.133114:0.886822:0.076190:0.886822:0.008376:0.009827:0.009223:0.005125:0.009827:0.010357:0.004188
Loop diuretics :@0.090478:0.916863:0.198307:0.916863:0.198307:0.900365:0.090478:0.900365:0.006652:0.009676:0.009676:0.009979:0.005927:0.009979:0.003629:0.009071:0.004838:0.009676:0.004536:0.003629:0.009676:0.006652:0.004233
are classically labelled as high-ceiling :@0.199985:0.916863:0.485145:0.916863:0.485145:0.901081:0.199985:0.901081:0.010326:0.004551:0.009827:0.005851:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.005881:0.003024:0.010326:0.010311:0.009827:0.003024:0.003024:0.009827:0.010357:0.005866:0.010326:0.005866:0.005866:0.009223:0.003024:0.010175:0.009223:0.005020:0.009782:0.009827:0.003024:0.003024:0.003024:0.009223:0.010175:0.004188
diuretics, as they may be used in high doses, with mini-:@0.076190:0.931122:0.480927:0.931122:0.480927:0.915339:0.076190:0.915339:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.004188:0.004899:0.010326:0.005866:0.004914:0.005125:0.009223:0.009827:0.008104:0.004914:0.014182:0.010326:0.008104:0.004914:0.010311:0.009827:0.004899:0.009192:0.005866:0.009827:0.010357:0.004899:0.003024:0.009223:0.004899:0.009223:0.003024:0.010175:0.009223:0.004899:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.004899:0.012564:0.003024:0.005125:0.009223:0.004899:0.014182:0.003024:0.009223:0.003024:0.005020
mal side effects. As mentioned, there should be close :@0.076190:0.945381:0.485130:0.945381:0.485130:0.929598:0.076190:0.929598:0.014182:0.010326:0.003024:0.005942:0.005866:0.003024:0.010357:0.009827:0.005942:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.005927:0.011188:0.005866:0.005927:0.014182:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.009827:0.010357:0.004188:0.005927:0.005125:0.009223:0.009827:0.004551:0.009827:0.005927:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005927:0.010311:0.009827:0.005927:0.009782:0.003024:0.009903:0.005866:0.009827:0.004188
monitoring  of  renal  failure and  hypokalaemia. Com-:@0.519042:0.084944:0.923794:0.084944:0.923794:0.069162:0.519042:0.069162:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003024:0.009223:0.010175:0.004188:0.003886:0.009903:0.004747:0.004188:0.003886:0.004551:0.009827:0.009223:0.010326:0.003024:0.004188:0.003886:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.008089:0.010326:0.009223:0.010357:0.004188:0.003886:0.009223:0.008104:0.010311:0.009903:0.007590:0.010326:0.003024:0.010326:0.009827:0.014182:0.003024:0.010326:0.004188:0.008089:0.012292:0.009903:0.014182:0.005020
monly used loop diuretics include furosemide, torasem-:@0.519042:0.099434:0.923809:0.099434:0.923809:0.083651:0.519042:0.083651:0.014182:0.009903:0.009223:0.003024:0.008104:0.004385:0.009192:0.005866:0.009827:0.010357:0.004385:0.003024:0.009903:0.009903:0.010311:0.004385:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.004385:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.004385:0.004747:0.009192:0.004551:0.009903:0.005866:0.009827:0.014182:0.003024:0.010357:0.009827:0.004188:0.004385:0.005125:0.009903:0.004551:0.010326:0.005866:0.009827:0.014182:0.005020
ide and bumetanide. :@0.519042:0.113924:0.680302:0.113924:0.680302:0.098141:0.519042:0.098141:0.003024:0.010357:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.009192:0.014182:0.009827:0.005125:0.010326:0.009223:0.003024:0.010357:0.009827:0.004188:0.004188
Thiazide/thiazide-like diuretics typically include hydro-:@0.533330:0.128413:0.923809:0.128413:0.923809:0.112630:0.533330:0.112630:0.006441:0.009223:0.003024:0.010326:0.006426:0.003024:0.010357:0.009827:0.006607:0.005125:0.009223:0.003024:0.010326:0.006426:0.003024:0.010357:0.009827:0.005020:0.003024:0.003024:0.007590:0.009827:0.004067:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.004052:0.005125:0.008104:0.010311:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.004067:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.004067:0.009223:0.008104:0.010357:0.004551:0.009903:0.005020
chlorothiazide  and indapamide.  potassium-sparing :@0.519042:0.142903:0.927982:0.142903:0.927982:0.127120:0.519042:0.127120:0.009782:0.009223:0.003024:0.009903:0.004551:0.009903:0.005125:0.009223:0.003024:0.010326:0.006426:0.003024:0.010357:0.009827:0.004188:0.010825:0.010326:0.009223:0.010357:0.015028:0.003024:0.009223:0.010357:0.010326:0.010311:0.010326:0.014182:0.003024:0.010357:0.009827:0.004188:0.004188:0.010825:0.008950:0.009903:0.005125:0.010326:0.005866:0.005866:0.003024:0.009192:0.014182:0.005020:0.005866:0.010311:0.010326:0.004551:0.003024:0.009223:0.010175:0.004188
diuretics have also been used, including amiloride and :@0.519042:0.157392:0.927952:0.157392:0.927952:0.141610:0.519042:0.141610:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.004762:0.009223:0.010326:0.008376:0.009827:0.004762:0.010326:0.003024:0.005866:0.009903:0.004762:0.010311:0.009827:0.009827:0.009223:0.004762:0.009192:0.005866:0.009827:0.010357:0.004188:0.004762:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.004762:0.010326:0.014182:0.003024:0.003024:0.009903:0.004551:0.003024:0.010357:0.009827:0.004762:0.010326:0.009223:0.010357:0.004188
triamterene. Again, exercise caution when using com-:@0.519042:0.171882:0.923779:0.171882:0.923779:0.156099:0.519042:0.156099:0.005125:0.004551:0.003024:0.010326:0.014182:0.005125:0.009827:0.004551:0.009827:0.009223:0.009827:0.004188:0.005503:0.011188:0.010175:0.010326:0.003024:0.009223:0.004188:0.005518:0.009827:0.007257:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827:0.005518:0.009782:0.010326:0.009192:0.005125:0.003024:0.009903:0.009223:0.005518:0.012564:0.009223:0.009827:0.009223:0.005518:0.009192:0.005866:0.003024:0.009223:0.010175:0.005518:0.009782:0.009903:0.014182:0.005020
bination therapy, as significant electrolyte disturbances :@0.519042:0.186371:0.927997:0.186371:0.927997:0.170589:0.519042:0.170589:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004415:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004415:0.010326:0.005866:0.004415:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004415:0.009827:0.003024:0.009827:0.009782:0.005125:0.004551:0.009903:0.003024:0.008104:0.005125:0.009827:0.004400:0.010357:0.003024:0.005866:0.005125:0.009192:0.004551:0.010311:0.010326:0.009223:0.009782:0.009827:0.005866:0.004188
may occur.:@0.519042:0.200861:0.603240:0.200861:0.603240:0.185078:0.519042:0.185078:0.014182:0.010326:0.008104:0.004188:0.009903:0.009782:0.009782:0.009192:0.004551:0.004188
ivabradine:@0.519047:0.232365:0.607745:0.232365:0.607745:0.214033:0.519047:0.214033:0.004704:0.009407:0.011087:0.011087:0.005376:0.011087:0.011087:0.004032:0.010079:0.010751
Ivabradine has been shown to reduce the combined :@0.519047:0.249022:0.928017:0.249022:0.928017:0.233239:0.519047:0.233239:0.003417:0.008376:0.010326:0.010311:0.004551:0.010326:0.010357:0.003024:0.009223:0.009827:0.006395:0.009223:0.010326:0.005866:0.006320:0.010311:0.009827:0.009827:0.009223:0.006320:0.005866:0.009223:0.009903:0.012564:0.009223:0.006320:0.005125:0.009903:0.006320:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.006320:0.005125:0.009223:0.009827:0.006320:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.010357:0.004188
 :@0.598785:0.249022:0.603018:0.249022:0.603018:0.232523:0.598785:0.232523:0.004233
endpoint of hospitalisation and mortality in heart failure :@0.519047:0.263511:0.928017:0.263511:0.928017:0.247728:0.519047:0.247728:0.009827:0.009223:0.010357:0.010311:0.009903:0.003024:0.009223:0.005125:0.004369:0.009903:0.004747:0.004369:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004385:0.010326:0.009223:0.010357:0.004369:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004369:0.003024:0.009223:0.004369:0.009223:0.009827:0.010326:0.004551:0.005125:0.004354:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188
in patients with symptomatic heart failure with an LVEF :@0.519047:0.278001:0.928017:0.278001:0.928017:0.262218:0.519047:0.262218:0.003024:0.009223:0.005201:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005201:0.012564:0.003024:0.005125:0.009223:0.005201:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.005201:0.009223:0.009827:0.010326:0.004551:0.005125:0.005186:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005201:0.012564:0.003024:0.005125:0.009223:0.005186:0.010326:0.009223:0.005201:0.006985:0.010614:0.008104:0.007333:0.004188
<35% and patients in sinus rhythm with a heart rate over :@0.519047:0.292490:0.928002:0.292490:0.928002:0.276708:0.519047:0.276708:0.009162:0.008376:0.008376:0.011717:0.004082:0.010326:0.009223:0.010357:0.004082:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004082:0.003024:0.009223:0.004082:0.005866:0.003024:0.009223:0.009192:0.005866:0.004082:0.004551:0.009223:0.008104:0.005125:0.009223:0.014182:0.004067:0.012564:0.003024:0.005125:0.009223:0.004082:0.010326:0.004082:0.009223:0.009827:0.010326:0.004551:0.005125:0.004067:0.004551:0.010326:0.005125:0.009827:0.004067:0.009903:0.008376:0.009827:0.004551:0.004188
70 beats/minute (SHIFT trial). Survival benefit was noted :@0.519047:0.306980:0.927987:0.306980:0.927987:0.291197:0.519047:0.291197:0.008376:0.008376:0.004808:0.010311:0.009827:0.010326:0.005125:0.005866:0.006607:0.014182:0.003024:0.009223:0.009192:0.005125:0.009827:0.004808:0.005579:0.007529:0.010326:0.003417:0.007333:0.006441:0.004808:0.005125:0.004551:0.003024:0.010326:0.003024:0.005579:0.004188:0.004808:0.007529:0.009192:0.004551:0.008376:0.003024:0.008376:0.010326:0.003024:0.004823:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004793:0.012564:0.010326:0.005866:0.004808:0.009223:0.009903:0.005125:0.009827:0.010357:0.004188
in patients with a heart rate in excess of 75 beats per :@0.519047:0.321469:0.928002:0.321469:0.928002:0.305687:0.519047:0.305687:0.003024:0.009223:0.006032:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006032:0.012564:0.003024:0.005125:0.009223:0.006032:0.010326:0.006032:0.009223:0.009827:0.010326:0.004551:0.005125:0.006017:0.004551:0.010326:0.005125:0.009827:0.006017:0.003024:0.009223:0.006032:0.009827:0.007257:0.009782:0.009827:0.005866:0.005866:0.006032:0.009903:0.004747:0.006032:0.008376:0.008376:0.006032:0.010311:0.009827:0.010326:0.005125:0.005866:0.006032:0.010311:0.009827:0.004551:0.004188
minute. This agent should not be used in patients in atrial :@0.519047:0.335959:0.927987:0.335959:0.927987:0.320176:0.519047:0.320176:0.014182:0.003024:0.009223:0.009192:0.005125:0.009827:0.004188:0.003387:0.006441:0.009223:0.003024:0.005866:0.003387:0.010326:0.010175:0.009827:0.009223:0.005125:0.003387:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003387:0.009223:0.009903:0.005125:0.003387:0.010311:0.009827:0.003387:0.009192:0.005866:0.009827:0.010357:0.003387:0.003024:0.009223:0.003387:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003387:0.003024:0.009223:0.003387:0.010326:0.005125:0.004551:0.003024:0.010326:0.003024:0.004188
fibrillation.:@0.519047:0.350448:0.592133:0.350448:0.592133:0.334666:0.519047:0.334666:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
Hydralazine and isosorbide dinitrate combination:@0.519047:0.381971:0.919198:0.381971:0.919198:0.363639:0.519047:0.363639:0.011423:0.009743:0.011087:0.005376:0.011087:0.004032:0.011087:0.007728:0.004032:0.010079:0.010751:0.004704:0.011087:0.010079:0.011087:0.004704:0.004032:0.007392:0.010751:0.007392:0.010751:0.005376:0.011087:0.004032:0.011087:0.010751:0.004704:0.011087:0.004032:0.010079:0.004032:0.005040:0.005376:0.011087:0.005040:0.010751:0.004704:0.010751:0.010751:0.015791:0.011087:0.004032:0.010079:0.011087:0.005040:0.004032:0.010751:0.010079
In black patients of African descent, the combination :@0.519047:0.398627:0.927987:0.398627:0.927987:0.382844:0.519047:0.382844:0.003417:0.009223:0.006048:0.010311:0.003024:0.010326:0.009782:0.007590:0.006063:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006063:0.009903:0.004747:0.006048:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.009223:0.006048:0.010357:0.009827:0.005866:0.009782:0.009827:0.009223:0.005125:0.004188:0.006048:0.005125:0.009223:0.009827:0.006048:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
of hydralazine and isosorbide dinitrate has been shown :@0.519047:0.413117:0.928017:0.413117:0.928017:0.397334:0.519047:0.397334:0.009903:0.004747:0.004460:0.009223:0.008104:0.010357:0.004551:0.010326:0.003024:0.010326:0.006426:0.003024:0.009223:0.009827:0.004460:0.010326:0.009223:0.010357:0.004460:0.003024:0.005866:0.009903:0.005866:0.009903:0.004551:0.010311:0.003024:0.010357:0.009827:0.004460:0.010357:0.003024:0.009223:0.003024:0.005125:0.004551:0.010326:0.005125:0.009827:0.004460:0.009223:0.010326:0.005866:0.004460:0.010311:0.009827:0.009827:0.009223:0.004460:0.005866:0.009223:0.009903:0.012564:0.009223:0.004188
to reduce hospitalisation and death in patients with a :@0.519047:0.427606:0.928002:0.427606:0.928002:0.411824:0.519047:0.411824:0.005125:0.009903:0.005851:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.005851:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.005851:0.010326:0.009223:0.010357:0.005851:0.010357:0.009827:0.010326:0.005125:0.009223:0.005851:0.003024:0.009223:0.005851:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005851:0.012564:0.003024:0.005125:0.009223:0.005851:0.010326:0.004188
left ventricular ejection fraction <35%. This combination :@0.519047:0.442096:0.928002:0.442096:0.928002:0.426313:0.519047:0.426313:0.003024:0.009827:0.004747:0.005125:0.004702:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004702:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004687:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004687:0.009162:0.008376:0.008376:0.011717:0.004188:0.004702:0.006441:0.009223:0.003024:0.005866:0.004702:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
may furthermore be used in patients unable to tolerate :@0.519047:0.456585:0.928017:0.456585:0.928017:0.440803:0.519047:0.440803:0.014182:0.010326:0.008104:0.004430:0.004747:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.014182:0.009903:0.004551:0.009827:0.004400:0.010311:0.009827:0.004430:0.009192:0.005866:0.009827:0.010357:0.004430:0.003024:0.009223:0.004430:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004430:0.009192:0.009223:0.010326:0.010311:0.003024:0.009827:0.004430:0.005125:0.009903:0.004415:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.004188
ACE inhibitors or ARBs. This combination should not be :@0.519047:0.471075:0.927987:0.471075:0.927987:0.455292:0.519047:0.455292:0.011188:0.012292:0.008104:0.005730:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.005730:0.009903:0.004551:0.005715:0.011188:0.009177:0.008678:0.005866:0.004188:0.005730:0.006441:0.009223:0.003024:0.005866:0.005730:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005730:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005730:0.009223:0.009903:0.005125:0.005715:0.010311:0.009827:0.004188
used routinely in all patients with heart failure, as sup-:@0.519047:0.485564:0.923784:0.485564:0.923784:0.469782:0.519047:0.469782:0.009192:0.005866:0.009827:0.010357:0.006184:0.004551:0.009888:0.009192:0.005125:0.003024:0.009223:0.009827:0.003024:0.008104:0.006184:0.003024:0.009223:0.006184:0.010326:0.003024:0.003024:0.006184:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006184:0.012564:0.003024:0.005125:0.009223:0.006184:0.009223:0.009827:0.010326:0.004551:0.005125:0.006169:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.006184:0.010326:0.005866:0.006184:0.005866:0.009192:0.010311:0.005020
portive studies were small and mainly centred on pa-:@0.519047:0.500054:0.923784:0.500054:0.923784:0.484271:0.519047:0.484271:0.010311:0.009903:0.004551:0.005125:0.003024:0.008376:0.009827:0.006244:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.006244:0.012564:0.009827:0.004551:0.009827:0.006229:0.005866:0.014182:0.010326:0.003024:0.003024:0.006244:0.010326:0.009223:0.010357:0.006244:0.014182:0.010326:0.003024:0.009223:0.003024:0.008104:0.006244:0.009782:0.009827:0.009223:0.005125:0.004551:0.009827:0.010357:0.006229:0.009903:0.009223:0.006229:0.010311:0.010326:0.005020
tients of African descent. These agents are usually add-:@0.519047:0.514543:0.923784:0.514543:0.923784:0.498761:0.519047:0.498761:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004203:0.009903:0.004747:0.004203:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.009223:0.004203:0.010357:0.009827:0.005866:0.009782:0.009827:0.009223:0.005125:0.004188:0.004203:0.006441:0.009223:0.009827:0.005866:0.009827:0.004203:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004203:0.010326:0.004551:0.009827:0.004203:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.004218:0.010326:0.010357:0.010357:0.005020
ed to conventional therapy.:@0.519047:0.529033:0.725437:0.529033:0.725437:0.513250:0.519047:0.513250:0.009827:0.010357:0.004188:0.005125:0.009903:0.004188:0.009782:0.009903:0.009223:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188
Other treatments:@0.519047:0.560546:0.655454:0.560546:0.655454:0.542214:0.519047:0.542214:0.014111:0.005040:0.010079:0.010751:0.005376:0.004704:0.005040:0.005376:0.010751:0.011087:0.005040:0.015791:0.010751:0.010079:0.005040:0.007392
Other treatments with a less certain benefit in sympto:@0.519047:0.577202:0.918779:0.577202:0.918779:0.561420:0.519047:0.561420:0.013138:0.005125:0.009223:0.009827:0.004551:0.005564:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005866:0.005564:0.012564:0.003024:0.005125:0.009223:0.005579:0.010326:0.005579:0.003024:0.009827:0.005866:0.005866:0.005579:0.009782:0.009827:0.004551:0.005125:0.010326:0.003024:0.009223:0.005564:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005564:0.003024:0.009223:0.005579:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903
-:@0.918779:0.577202:0.923799:0.577202:0.923799:0.561420:0.918779:0.561420:0.005020
matic patients with heart failure with reduced ejection :@0.519047:0.591692:0.927987:0.591692:0.927987:0.575909:0.519047:0.575909:0.014182:0.010326:0.005125:0.003024:0.009782:0.005171:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005171:0.012564:0.003024:0.005125:0.009223:0.005171:0.009223:0.009827:0.010326:0.004551:0.005125:0.005171:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005171:0.012564:0.003024:0.005125:0.009223:0.005171:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.005171:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
fraction include digoxin and other digitalis glycosides. :@0.519047:0.606181:0.927987:0.606181:0.927987:0.590399:0.519047:0.590399:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.006335:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.006350:0.010357:0.003024:0.010175:0.009903:0.007257:0.003024:0.009223:0.006350:0.010326:0.009223:0.010357:0.006350:0.009903:0.005125:0.009223:0.009827:0.004551:0.006335:0.010357:0.003024:0.010175:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.006365:0.010175:0.003024:0.008104:0.009782:0.009903:0.005866:0.003024:0.010357:0.009827:0.005866:0.004188:0.004188
Recent  studies suggest a higher  risk of events (heart :@0.519047:0.620671:0.928002:0.620671:0.928002:0.604888:0.519047:0.604888:0.009177:0.009827:0.009782:0.009827:0.009223:0.005125:0.004188:0.003477:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.007680:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.007680:0.010326:0.007680:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004188:0.003477:0.004551:0.003024:0.005866:0.007590:0.007680:0.009903:0.004747:0.007680:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.007680:0.005579:0.009223:0.009827:0.010326:0.004551:0.005125:0.004188
failure, hospitalisation and death) in patients who have :@0.519047:0.635161:0.928002:0.635161:0.928002:0.619378:0.519047:0.619378:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.004536:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004536:0.010326:0.009223:0.010357:0.004536:0.010357:0.009827:0.010326:0.005125:0.009223:0.005579:0.004536:0.003024:0.009223:0.004536:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004536:0.012564:0.009223:0.009903:0.004521:0.009223:0.010326:0.008376:0.009827:0.004188
atrial fibrillation with heart failure, and receive digoxin. :@0.519047:0.649650:0.927987:0.649650:0.927987:0.633867:0.519047:0.633867:0.010326:0.005125:0.004551:0.003024:0.010326:0.003024:0.005624:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005624:0.012564:0.003024:0.005125:0.009223:0.005624:0.009223:0.009827:0.010326:0.004551:0.005125:0.005609:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.005609:0.010326:0.009223:0.010357:0.005624:0.004551:0.009827:0.009782:0.009827:0.003024:0.008376:0.009827:0.005624:0.010357:0.003024:0.010175:0.009903:0.007257:0.003024:0.009223:0.004188:0.004188
However, this has been a highly controversial topic as :@0.519047:0.664140:0.928002:0.664140:0.928002:0.648357:0.519047:0.648357:0.010326:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.005806:0.005125:0.009223:0.003024:0.005866:0.005806:0.009223:0.010326:0.005866:0.005806:0.010311:0.009827:0.009827:0.009223:0.005806:0.010326:0.005806:0.009223:0.003024:0.010175:0.009223:0.003024:0.008104:0.005806:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.008376:0.009827:0.004551:0.005866:0.003024:0.010326:0.003024:0.005806:0.005125:0.009903:0.010311:0.003024:0.009782:0.005806:0.010326:0.005866:0.004188
other studies have found no harmful effects in the same :@0.519047:0.678629:0.927987:0.678629:0.927987:0.662846:0.519047:0.662846:0.009903:0.005125:0.009223:0.009827:0.004551:0.003855:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.003870:0.009223:0.010326:0.008376:0.009827:0.003870:0.004747:0.009903:0.009192:0.009223:0.010357:0.003855:0.009223:0.009903:0.003855:0.009223:0.010326:0.004551:0.014182:0.004747:0.009192:0.003024:0.003870:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.003870:0.003024:0.009223:0.003870:0.005125:0.009223:0.009827:0.003855:0.005866:0.010326:0.014182:0.009827:0.004188
clinical setting. Digoxin is best avoided in cases of renal :@0.519047:0.693119:0.927987:0.693119:0.927987:0.677336:0.519047:0.677336:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004385:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.004188:0.004369:0.011249:0.003024:0.010175:0.009903:0.007257:0.003024:0.009223:0.004385:0.003024:0.005866:0.004385:0.010311:0.009827:0.005866:0.005125:0.004385:0.010326:0.008376:0.009903:0.003024:0.010357:0.009827:0.010357:0.004385:0.003024:0.009223:0.004385:0.009782:0.010326:0.005866:0.009827:0.005866:0.004385:0.009903:0.004747:0.004369:0.004551:0.009827:0.009223:0.010326:0.003024:0.004188
failure and a history of toxicity. Digoxin may be explored :@0.519047:0.707608:0.928017:0.707608:0.928017:0.691826:0.519047:0.691826:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.003583:0.010326:0.009223:0.010357:0.003583:0.010326:0.003583:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.003568:0.009903:0.004747:0.003568:0.005125:0.009903:0.007257:0.003024:0.009782:0.003024:0.005125:0.008104:0.004188:0.003583:0.011249:0.003024:0.010175:0.009903:0.007257:0.003024:0.009223:0.003583:0.014182:0.010326:0.008104:0.003583:0.010311:0.009827:0.003583:0.009827:0.007257:0.010311:0.003024:0.009903:0.004551:0.009827:0.010357:0.004188
when other therapeutic options cannot be pursued. Di-:@0.519047:0.722098:0.923799:0.722098:0.923799:0.706315:0.519047:0.706315:0.012564:0.009223:0.009827:0.009223:0.004158:0.009903:0.005125:0.009223:0.009827:0.004551:0.004158:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.009827:0.009192:0.005125:0.003024:0.009782:0.004158:0.009903:0.010311:0.005125:0.003024:0.009903:0.009223:0.005866:0.004173:0.009782:0.010326:0.009223:0.009223:0.009903:0.005125:0.004158:0.010311:0.009827:0.004158:0.010311:0.009192:0.004551:0.005866:0.009192:0.009827:0.010357:0.004188:0.004158:0.011249:0.003024:0.005020
goxin should be prescribed under specialist supervision :@0.519047:0.736587:0.928002:0.736587:0.928002:0.720805:0.519047:0.720805:0.010175:0.009903:0.007257:0.003024:0.009223:0.005095:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005095:0.010311:0.009827:0.005095:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.005095:0.009192:0.009223:0.010357:0.009827:0.004551:0.005095:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.005110:0.005866:0.009192:0.010311:0.009827:0.004551:0.008376:0.003024:0.005866:0.003024:0.009903:0.009223:0.004188
and the monitoring of digoxin levels.:@0.519047:0.751077:0.784144:0.751077:0.784144:0.735294:0.519047:0.735294:0.010326:0.009223:0.010357:0.004188:0.005125:0.009223:0.009827:0.004188:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003024:0.009223:0.010175:0.004188:0.009903:0.004747:0.004188:0.010357:0.003024:0.010175:0.009903:0.007257:0.003024:0.009223:0.004188:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188
nOn-PHArmACOlOGiCAl treAtment:@0.519047:0.784252:0.860166:0.784252:0.860166:0.764087:0.519047:0.764087:0.013674:0.015522:0.013674:0.007761:0.010348:0.012566:0.013674:0.010718:0.016631:0.013674:0.014413:0.015522:0.008131:0.015522:0.015522:0.005174:0.014413:0.013674:0.008131:0.005174:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761
Cardiac resynchronisation therapy, with or without an :@0.519047:0.800515:0.927987:0.800515:0.927987:0.784732:0.519047:0.784732:0.012292:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.006274:0.004551:0.009827:0.005866:0.008104:0.009223:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.006259:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.006274:0.012564:0.003024:0.005125:0.009223:0.006274:0.009903:0.004551:0.006259:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.006259:0.010326:0.009223:0.004188
intracardiac  defibrillator  (CRT/CRT-D),  is  supported  by :@0.519047:0.815004:0.927987:0.815004:0.927987:0.799222:0.519047:0.799222:0.003024:0.009223:0.005125:0.004551:0.010326:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.004188:0.003054:0.010357:0.009827:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024:0.003024:0.010326:0.005125:0.009903:0.004551:0.004188:0.003039:0.005579:0.012292:0.009177:0.006441:0.006607:0.012292:0.009177:0.006441:0.005020:0.011249:0.005579:0.004188:0.004188:0.003054:0.003024:0.005866:0.004188:0.003054:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.009827:0.010357:0.004188:0.003039:0.010311:0.008104:0.004188
a host of clinical trials for mortality benefit, reduction in :@0.519047:0.829494:0.927972:0.829494:0.927972:0.813711:0.519047:0.813711:0.010326:0.004989:0.009223:0.009903:0.005866:0.005125:0.004989:0.009903:0.004747:0.004989:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004989:0.005125:0.004551:0.003024:0.010326:0.003024:0.005866:0.004989:0.004747:0.009903:0.004551:0.004974:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004989:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188:0.004974:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004974:0.003024:0.009223:0.004188
hospital admissions and improvement in the quality of :@0.519047:0.843983:0.928017:0.843983:0.928017:0.828201:0.519047:0.828201:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.005957:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005866:0.005972:0.010326:0.009223:0.010357:0.005957:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.005957:0.003024:0.009223:0.005957:0.005125:0.009223:0.009827:0.005957:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.005972:0.009903:0.004747:0.004188
life. Cardiac resynchronisation devices (specialised bi-:@0.519047:0.858473:0.923814:0.858473:0.923814:0.842690:0.519047:0.842690:0.003024:0.003024:0.004747:0.009827:0.004188:0.006063:0.012292:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.006063:0.004551:0.009827:0.005866:0.008104:0.009223:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.006063:0.010357:0.009827:0.008376:0.003024:0.009782:0.009827:0.005866:0.006063:0.005579:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.009827:0.010357:0.006078:0.010311:0.003024:0.005020
ventricular pacemakers) are indicated, in the presence :@0.519047:0.872962:0.928017:0.872962:0.928017:0.857180:0.519047:0.857180:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004007:0.010311:0.010326:0.009782:0.009827:0.014182:0.010326:0.007590:0.009827:0.004551:0.005866:0.005579:0.004007:0.010326:0.004551:0.009827:0.004007:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004188:0.004007:0.003024:0.009223:0.004007:0.005125:0.009223:0.009827:0.004007:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.004188
of specific criteria, i.e. in the presence of a left bundle :@0.519047:0.887452:0.927972:0.887452:0.927972:0.871669:0.519047:0.871669:0.009903:0.004747:0.005322:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.005322:0.009782:0.004551:0.003024:0.005125:0.009827:0.004551:0.003024:0.010326:0.004188:0.005322:0.003024:0.004188:0.009827:0.004188:0.005322:0.003024:0.009223:0.005322:0.005125:0.009223:0.009827:0.005322:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.005322:0.009903:0.004747:0.005322:0.010326:0.005337:0.003024:0.009827:0.004747:0.005125:0.005322:0.010311:0.009192:0.009223:0.010357:0.003024:0.009827:0.004188
branch block, where symptoms are functionally limiting, :@0.519047:0.901941:0.927987:0.901941:0.927987:0.886159:0.519047:0.886159:0.010311:0.004551:0.010326:0.009223:0.009782:0.009223:0.003765:0.010311:0.003024:0.009903:0.009782:0.007590:0.004188:0.003765:0.012564:0.009223:0.009827:0.004551:0.009827:0.003765:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.003780:0.010326:0.004551:0.009827:0.003765:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003024:0.008104:0.003780:0.003024:0.003024:0.014182:0.003024:0.005125:0.003024:0.009223:0.010175:0.004188:0.004188
despite optimal pharmacological therapy. Implantable :@0.519047:0.916431:0.927987:0.916431:0.927987:0.900648:0.519047:0.900648:0.010357:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.003976:0.009903:0.010311:0.005125:0.003024:0.014182:0.010326:0.003024:0.003976:0.010311:0.009223:0.010326:0.004551:0.014182:0.010326:0.009782:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.003976:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003976:0.003417:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.010326:0.010311:0.003024:0.009827:0.004188
defibrillator devices prevent sudden cardiac death due :@0.519047:0.930921:0.927987:0.930921:0.927987:0.915138:0.519047:0.915138:0.010357:0.009827:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024:0.003024:0.010326:0.005125:0.009903:0.004551:0.003644:0.010357:0.009827:0.008376:0.003024:0.009782:0.009827:0.005866:0.003644:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003644:0.005866:0.009192:0.010357:0.010357:0.009827:0.009223:0.003644:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.003644:0.010357:0.009827:0.010326:0.005125:0.009223:0.003644:0.010357:0.009192:0.009827:0.004188
to malignant arrhythmias (ventricular tachycardia or :@0.519047:0.945410:0.927987:0.945410:0.927987:0.929627:0.519047:0.929627:0.005125:0.009903:0.008527:0.014182:0.010326:0.003024:0.003024:0.010175:0.009223:0.010326:0.009223:0.005125:0.008527:0.010326:0.004551:0.004551:0.009223:0.008104:0.005125:0.009223:0.014182:0.003024:0.010326:0.005866:0.008527:0.005579:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.008527:0.005125:0.010326:0.009782:0.009223:0.008104:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.008527:0.009903:0.004551:0.004188